Delivery Order SPE2DB20D2104-SPE2DB25FMQRX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,237.86 to AmerisourceBergen Drug Corp for Savella 100 mg tablets (60-count units) on August 13, 2025, with completion targeted for August 14, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. Savella (milnacipran) is a serotonin-norepinephrine reuptake inhibitor indicated for fibromyalgia...
- The Defense Logistics Agency awarded a delivery order valued at $1,094.34 to AmerisourceBergen Drug Corp for the supply of Savella (milnacipran) 50 mg tablets in a quantity of 60 units. This contract, designated as a firm fixed price delivery order, was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025. The award represents a non-competitive, non-set-aside transaction and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,321.20 to AmerisourceBergen Drug Corp for 60 tablets of Savella 12.5 mg on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Savella (milnacipran) is a serotonin-norepinephrine reuptake inhibitor used primarily for fibromyalgia...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Savella 100 mg tablets (60-count units) with a ceiling value of $4,750.50. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a non-set-aside competitive award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Savella (milnacipran) is a serotonin-norepinephrine reuptake inhibitor...
- The Defense Logistics Agency awarded a $1,580.37 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Savella (milnacipran) 50 mg tablets in a 60-count quantity. This firm fixed-price delivery order, with an ultimate completion date of September 8, 2025, represents a competitively awarded, non-set-aside contract for pharmaceutical procurement. The medication will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Savella 50 mg tablets (60-count units) with a contract value of $26,478.90. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Savella 25 mg tablets (60-count packaging) with a ceiling value of $4,676.17. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of August 14, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,064.07 to AmerisourceBergen Drug Corp for the supply of Savella 50 mg tablets (60-count units) on August 4, 2025, with completion expected by August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The product will be delivered to the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $18,324.20 to AmerisourceBergen Drug Corp for the supply of Savella (milnacipran) 100 mg tablets in quantities of 60 units. This competitively awarded, firm fixed-price contract has an ultimate completion date of August 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Savella (milnacipran) 25 mg tablets in a 60-count package, with a ceiling value of $7,351.78. This non-set-aside, competitively awarded contract employs firm fixed pricing and has an ultimate completion date of May 13, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMQRXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,275.27 to AmerisourceBergen Drug Corp for the supply of Savella 50 mg tablets (60-count units). This firm fixed price contract, awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-set-aside competitive award. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Savella (milnacipran) is a centrally acting analgesic used primarily for fibromyalgia pain management, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement needs to support military and veteran healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.9 billion prime vendor agreement running through December 2026. As a major pharmaceutical distributor, AmerisourceBergen leverages this comprehensive global contract vehicle to supply an extensive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to meet federal procurement requirements and serve critical healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 8/6/25 |